Patients with psychotic disorders are often treated with numerous medications, many of which have anticholinergic activity. We assessed cognition in relation to the cumulative anticholinergic burden of multiple drugs included in treatment regimens of participants from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Clinically … ContinuedTagged: Anticholineric, Burden, Cognitive, Disorders, Medications, Psychotic
Recognized globally as experts in neurocognition and pharmacologic treatment of CNS disorders, the NeuroCog Trials Scientific Team has been instrumental in hundreds of research projects and clinical trials. Below are links to key articles that comprise a portion of our scientific library.
Validation of the Persian version of the Schizophrenia Cognition Rating Scale (SCoRS) in patients with schizophrenia
The Schizophrenia Cognition Rating Scale (SCoRS) is an interview-based assessment of cognition that involves interviews with patients and informants. The SCoRS has shown good reliability, validity, and sensitivity to cognitive impairment in schizophrenia, with the advantage of brief administration and scoring time. The present study … ContinuedTagged: Persian, Schizophrenia, SCoRS, Validation, Version
The validation study of our proprietary Brief Assessment of Cognition (BAC App) is now in press in Schizophrenia Research, available as Open Access PDF. To facilitate the administration of our widely-used pen-and-paper neurocognitive battery, the Brief Assessment of Cognition (BAC), we developed a regulatory compliant … ContinuedTagged: BAC App, Brief Assessment of Cognition, tablet, Validation
UPDATE SEPTEMBER 8, 2016: The prepublication of Neuroscience Trials of the Future: Proceedings of a Workshop is now available online at the National Academies Press. UPDATE APRIL 5, 2016: Presentations are now available for review at Neuroscience Trials of the Future: A Workshop (Click on Presentations … ContinuedTagged: future, Institute, Keefe, medicine. neuroscience, Pande, trials